AbbVie and FutureGen Enter License Agreement for Advanced Inflammatory Bowel Disease Therapy
Roche's PD-L1 Assay Receives Expanded CE Mark as Companion Diagnostic for Libtayo in Combination with Chemotherapy
Indian TB Diagnostic Technology Receives Praise at World Health Assembly
FDA Grants Accelerated Approval to Augtyro™ (Repotrectinib) for NTRK-Positive Locally Advanced or Metastatic Solid Tumors
QIAGEN ‘s QCI Interpret Software Enhances Clinical Reporting Speed for High-Throughput NGS Testing Labs
Approval Granted: Applied DNA's TR8(TM) Pharmacogenomic (PGx) Testing Service Receives Green Light from New York State Department of Health
Sirnaomics Unveils Robust Antitumor Efficacy of Novel Oligonucleotide-ChemoDrug Conjugate in Journal of Oncology Research and Therapy
QIAGEN Introduces Advanced QIAcuity Digital PCR Assays for Microbial Studies, Elevating Infectious Disease Research and Surveillance
DRAGEN v4.3 by Illumina: Advancing the Most Comprehensive and Accurate Genome with Cutting-Edge Innovations
Transforming Healthcare: The Rise of Genomic Urine Testing
Myriad Genetics Partners with GSK to Enhance HRD Testing Accessibility Across Nine Nations
Unveiling the Future of Cancer Care: Join Diaceutics' Virtual Event on Precision Medicine in Oncology
FDA Clears Abbott's Over-the-Counter Continuous Glucose Monitors
FDA Prioritizes AstraZeneca's Tagrisso sNDA for Priority Review in Unresectable Stage III NSCLC
Advancements in Biomarkers for Early Cancer Detection